Clinical nutrition\ Marché - N°64 and diversified offer population. Finally, the increase in the number ported by medical nutrition. Clinical nutrition of pre-term births, estimated at 15 million in accounts for 15.9% of its turnover (Nestlé 2017 (WHS), is also guiding the market, espe- 2017 Annual Report). “NHS is an entity that cially the one for infant nutrition. represents over 3,000 employees and 900 million products,” says Carole Bras (accor- The trend towards delisting ding to an interview by Carole Bras). This might change the data category does not include “classic” infant nutrition. Only the infant formulas dedicated The only shadow in the European landscape to children with allergies are covered by relates to the efforts made by made govern- NHS’ therapeutic dietary products. In order ments, including France, to cut down the to secure Nestlé’s position, Mark Schneider healthcare expenditure, which should lead to (Nestlé’s CEO) relies onseveral growth oppor- the delisting of certain medical nutrition pro- tunities such as “active ageing”(Meritene ducts and therefore slow down the market Mobilis, Boost Optimum, Nutren Senior).® ® growth (see the box on France). Nevertheless, Meeting the needs of this specifi c population this could offer prevention solutions within a group, who values prevention and self-medi- context favourable to their development. Val- cation, and expanding the offering available biotis, which is committed to innovation in in pharmacies and health & beauty stores are an effort to support prevention and the fi ght some of the mentioned strategies (seminary of against metabolic diseases, estimates the investors, September 2017). He also specu- 013 prevention market at €150 billion: 48 billion lates on the products allowing for a reduction for overweight, 38 billion for pre-diabetes, 34 of the healthcare expenditure by stimulating billion for non-alcoholic steatohepatitis and 26 the immune system (Impact) or by fi ghting® billion for hypercholesterolemia. against malnutrition (Peptamen Intense),® or the expansion into emerging markets Five key players to follow (Boost Energis, Boost Mobilis adapted to® ® the Chinese market) and the reformulation The global clinical nutrition market is currentlyof nutrition products with simple ingredients dominated by fi ve major players: Abbott Nutri- (Boost Simply Complete) or real food ingre-® tion, Nestlé, Nutricia (Danone), Mead Johnson dients (Compleat Pediatric). The Swiss giant® and Fresenius Kabi. is also focused on the group’s transition to Abbott Nutrition has been the global leader nutrition, health and well-being through new for years, especially due to the very good per- partnerships and acquisitions. July 2017, formance of its fl agship brand Ensure dedi-® Nestlé jointly created with Enterome a cated to adults in the developed countries and company specialized in microbiome-based emerging markets. On the other hand, its infant diagnostics for infl ammatory bowel diseases nutrition formulas Similac, PediaSure and® ® (IBD) and liver diseases, namely Microbiome Pedialytes experienced a sales drop in 2017® Diagnostics Partners. “Mastering the micro- because of a very diffi cult context in various biome is an important facet of our strategy emerging countries (fi nancial crisis, new food to develop the therapeutic role of nutrition. safety regulations). Still, in 2017 Abbott’s salesWe also see new opportunities for perso- amounted to over 7 billion and nutrition pro- nalized nutrition both for the healthy pou-p ducts account for 25% of its turnover. lation and the patients,” Greg Behar, CEO Nestlé is the second world’s leader in medical of Nestlé Health Science, said. In October nutrition (no. 1 in France) with a sales tur- 2017, Nestlé concluded a partnership with nover amounting to 4.8 billion dollars in 2017 Codexis, a company that develops enzy- in the segment Nestlé Health Science, whose matic solutions for the treatment of certain 2% growth as compared to 2016 was sup- nutritional diseases, such as phenylketonuria. News on Functional & Health Ingredients \ N°64 \ July - August - September 2018 \ ■